drugset / Trial / NCT01128712

Effect on Anxiety in Partial Epilepsy Patients Treated With Pregabalin

NCT01128712

Phase 4 Terminated 4 enrolled Northeast Regional Epilepsy Group Pfizer · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

To prospectively demonstrate the superior anxiolytic effect of high dose pregabalin (PGB) therapy (450 mg/day) compared to low dose PGB therapy (150 mg/day) in subjects with medically refractory partial epilepsy not fully controlled despite treatment with 1-2 concomitant antiepileptic drugs (AEDs).

Timeline

Start
2010-04
Primary completion
2014-07
Completion
2014-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 150 mg
Subject Pregabalin Small molecule 450 mg